FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer
The U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and ...
ARY News Live6d
VYLOY: Astellas’ gastric cancer therapy approved in US
Astellas Pharma today announced that the US Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in ...
pharmaphorum4d
FDA clears Astellas' Vyloy as first claudin 18.2 cancer drug
Vyloy is the first CLDN18.2-targeting drug to reach the US market but has already been approved in Japan as well as in the EU ...
GlobalData on MSN4d
FDA approves Astellas’ VYLOY for gastric cancer treatment
Astellas Pharma has gained approval from the US Food and Drug Administration (FDA) for VYLOY (zolbetuximab-clzb), in ...
FiercePharma10h
Fierce Pharma Asia—Astellas' first-in-class FDA nod; Otsuka's IgAN win; Samsung Bio's $1.2B contract
Astellas' first-in-class CLDN18.2 drug Vyloy has cleared the FDA. After a positive phase 3 readout, Otsuka is targeting an ...
WebMD1d
New First-in-Class Drug Approved for Advanced Stomach Cancer
The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.
The Pharma Letter6d
FDA approves Astellas’ Vyloy
The US Food and Drug Administration has approved Vyloy (zolbetuximab-clzb), a claudin 18.2 (CLDN18.2)-directed cytolytic ...
biopharma-reporter3d
FDA approves targeted therapy for gastric cancer and its companion diagnostic
The FDA has simultaneously granted approval to Astellas’ cancer drug Vyloy and to a companion diagnostic test developed by ...
Cancer Therapy Advisor4d
Vyloy Approved for Gastric, GEJ Cancer
The FDA has approved Vyloy (zolbetuximab-clzb) in combination with chemotherapy to treat advanced gastric or GEJ cancer.
devdiscourse5d
FDA Greenlights Vyloy for Gastric Cancer, Egypt Achieves Malaria-Free Status
The FDA has approved Astellas' Vyloy to treat gastric cancer. Egypt has been certified malaria-free by WHO. A Tennessee court ...
Yahoo Finance4d
FDA approves Astellas’ VYLOY for gastric cancer treatment
Astellas Pharma has gained approval from the US Food and Drug Administration (FDA) for VYLOY (zolbetuximab-clzb), in conjunction with chemotherapy, for the treatment of advanced gastric and ...